多西紫杉醇联合放疗用于中晚期鼻咽癌的疗效观察 |
| |
引用本文: | 刘文峰.多西紫杉醇联合放疗用于中晚期鼻咽癌的疗效观察[J].甘肃医药,2014,0(6):410-411. |
| |
作者姓名: | 刘文峰 |
| |
作者单位: | 刘文峰 (酒泉市第二人民医院肿瘤科, 甘肃 酒泉,735000); |
| |
摘 要: | 目的:观察多西紫杉醇联合放疗用于中晚期鼻咽癌的实际疗效,评价其临床应用价值。方法:回顾性分析42例中晚期鼻咽癌患者,按照治疗方式分为观察组21例,采用多西紫杉醇联合放疗进行治疗;以及对照组21例,采用单纯放疗进行治疗;比较两组患者治疗有效率及5年生存率。结果:应用多西紫杉醇联合放疗治疗的观察组临床改善明显优于对照组,治疗有效率及5年生存率组间差异均具有统计学意义(P<0.05)。结论:多西紫杉醇联合放疗用于中晚期鼻咽癌的治疗,具有疗效显著,安全可靠的特点,值得临床推广应用。
|
关 键 词: | 多西紫杉醇 中晚期 鼻咽癌 放疗 |
Clinical observation of docetaxel combined with radiotherapy for advanced nasopharyngeal carcinoma patients |
| |
Authors: | LIU Wen-feng |
| |
Affiliation: | LIU Wen-feng (Department of Oncology, the Second People's Hospital of Jiuquan City, Jiuquan 735000,China) |
| |
Abstract: | Objective:To observe the actual efficacy of paclitaxel combined with radiotherapy for advanced nasopharyngeal carcinoma patients, and to evaluate its clinical value. Methods: 42 patients with advanced nasopharyngeal carcinoma were divided into the observe group (21 cases, docetaxel combination with radiotherapy treatment),and the control group (21 cases,radiotherapy treatment) in which effective rate and 5-year survival rate were compared in two groups . Results: The clinical improvement of the observation group was significantly better than that in control group. The effective rate and 5-year survival rate were statistically significant (P<0.05) between two groups. Conclusion: The docetaxel combined with radiotherapy for the treatment of advanced nasopharyngeal carcinoma has a significant effect,safe and reliable, and be worthy of clinical application. |
| |
Keywords: | docetaxel advanced nasopharyngeal carcinoma radiotherapy |
本文献已被 CNKI 维普 等数据库收录! |
|